Home » Topics » BioWorld Science

BioWorld Science
RSS

Sesame oil shows beneficial effects in hypertensive patients

Aug. 19, 2004

Promising atypical antipsychotic agent by Sigma-Tau

Aug. 19, 2004

Improved histamine H3 antagonists/inverse agonists presented by Abbott

Aug. 18, 2004

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

Discovery of potent himbacine-based thrombin receptor antagonist

Aug. 18, 2004

Yamanouchi and Boehringer Ingelheim to copromote Flomax in U.S. for BPH

Aug. 18, 2004

Amgen completes acquisition of Tularik

Aug. 18, 2004

European approval for higher dosage of candesartan cilexetil

Aug. 18, 2004

MorphoSys and Boehringer Ingelheim initiate new antibody program

Aug. 18, 2004

Positive opinion for reimbursement of Advate in France

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...